News

A bankruptcy judge has approved the sale of 23andMe to the nonprofit TTAM Research Institute, owned by cofounder and former CEO of 23andMe Anne Wojcicki, thereby ensuring that the DNA of the company's ...
Suki, an AI-backed voice tool for healthcare, announced its expanded integration with Meditech, an EHR company, enabling Suki to generate and forward clinically generated notes directly into ...
Connor Glass, founder and CEO of Phantom Neuro, explains how the company's muscle-machine interface for amputees is enabling the development of advanced prosthetic limbs designed to function as ...
Abridge, a generative AI platform for clinical conversations, has raised $300 million in Series E funding, bringing its valuation to a reported $5.3 billion. Andreessen Horowitz ( a16z) led the round ...
The Guardian Life Insurance Company of America announced it is partnering with global fertility, family-building and hormonal health platform Carrot to provide Guardian members with access to Carrot's ...
The partnership has been terminated less than two months after launch as Novo Nordisk alleges Hims & Hers is illegally selling copycat drugs and using deceptive marketing practices.
Julien Payen, cofounder and CEO of Lattice Medical, discusses the company’s 3D-printed breast implant that supports women recovering from mastectomy using a scaffold that gradually dissolves as the ...
Editor's note: This article has been updated with a comment from Hims & Hers CEO and the company. Pharma giant Novo Nordisk announced that it is terminating its contract with direct-to-consumer ...
New York-based virtual women's health provider Maven Clinic is partnering with health-tracking ring maker Oura to allow Oura Ring wearers to sync their data with the Maven platform. Maven Clinic is a ...
Salvo Health, a digital gastrointestinal care company, raised $4 million in an extended Seed Prime round after announcing a $5 million investment in February of last year. New investor The Artemis ...
Viz.ai, a company involved in AI-backed imaging and care coordination, is collaborating with pharma giant Novartis to develop proprietary AI-powered workflows inside the Viz Oncology Suite. Viz.ai ...